Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Trevi Therapeutics, Inc. | Controller and Principal Accounting Officer | Common Stock | 19.9K | $10.2K | $0.51 | Dec 13, 2024 | Direct |
Trevi Therapeutics, Inc. | Controller and Principal Accounting Officer | Stock Option (right to buy) | 20K | Dec 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRVI | Trevi Therapeutics, Inc. | Dec 13, 2024 | 2 | $7.67K | 4 | Dec 17, 2024 | Controller and Principal Accounting Officer |
TRVI | Trevi Therapeutics, Inc. | Feb 15, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Controller and Principal Accounting Officer |
TRVI | Trevi Therapeutics, Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 16, 2023 | Controller and Principal Accounting Officer |
TRVI | Trevi Therapeutics, Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | Controller and Principal Accounting Officer |